TP53 and neoplasm: Interestingly, a recent USP2 inhibitor was found to activate p53 function and maintain the integrity of the p53-dependent MDM2 axis, which inhibits tumor growth in mice without exhibiting significant toxicity, similar to MDM2 inhibitors.208